Literature Review : Relationship Between Moyamoya Disease And Cerebral Iscemic Incidents
Keywords:
Moyamoya disease, stroke, revascularization .Abstract
Moyamoya disease is a rare progressive cerebrovascular disorder characterized by blockage of arteries at the base of the brain, causing ischemic and hemorrhagic strokes. This condition is most common in children and adults in Asia, with the main symptoms being transient ischemic attacks (TIAs) or strokes. This study used a literature review method by collecting data from various medical journals related to the diagnosis and management of Moyamoya. Diagnosis is generally made through MRI, MRA, and DSA, with DSA being the best method to identify arterial stenosis and collateral formation. The results showed that treatment included medical therapy with aspirin and surgical revascularization procedures to improve cerebral blood flow, where direct revascularization provides faster results although technically more difficult. Early diagnosis and surgical intervention are essential to prevent disease progression.
References
Gupta A, Tyagi A, Romo M, Amoroso KC, Sonia F. Moyamoya Disease: A Review of Current Literature. Cureus . 2020;12(8). doi:10.7759/cureus.10141
Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease (Review). Exp Ther Med . Published online 2019:1977-1984. doi:10.3892/etm.2019.7198
Zhang X, Xiao W, Zhang Q, et al. Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment. Curr Neuropharmacol . 2021;20(2):292-308. doi:10.2174/1570159x19666210716114016
Mertens R, Graupera M, Gerhardt H, et al. The Genetic Basis of Moyamoya Disease. Transl Stroke Res . 2022;13(1):25-45. doi:10.1007/s12975-021-00940-2
Tinelli F, Nava S, Arioli F, et al. Vascular remodeling in moyamoya angiopathy: From peripheral blood mononuclear cells to endothelial cells. Int J Mol Sci . 2020;21(16):1-22. doi:10.3390/ijms21165763
Fang YC, Wei LF, Hu CJ, Tu YK. Pathological circulating factors in moyamoya disease. Int J Mol Sci . 2021;22(4):1-12. doi:10.3390/ijms22041696
Dorschel KB, Wanebo JE. Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. Front Neurol . 2023;14. doi:10.3389/fneur.2023.661611
Yadav R, Pokhriyal SC, Yadav V, Idries I, Berekashvili K. The Role of Dual Antiplatelet Therapy (DAPT) vs Surgery in a Case of Moyamoya Disease: A Case Report and Review of the Literature. 2023;15(5). doi:10.7759/cureus.39694
Parchmont EC, Adler AC. Moyamoya Disease. Case Study Pediatric Anesthesia . 2019;1:164-168. doi:10.1017/9781108668736.039
Berry JA, Cortez V, Toor H, Saini H, Siddiqi J. Moyamoya: An Update and Review. Cureus . 2020 Oct 16;12(10 ):e 10994. doi : 10.7759/cureus.10994. PMID: 33209550; PMCID: PMC7667711
Unda SR, Antoniazzi AM, Miller R, Klyde D, Javed K, Fluss R, Holland R, De la Garza Ramos R, Haranhalli N, Altschul DJ. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors. J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105965. doi : 10.1016/j.jstrokecerebrovasdis.2021.105965. Epub 2021 Jul 8. Erratum in: J Stroke Cerebrovasc Dis. 2021 Dec;30(12):106150. doi : 10.1016/j.jstrokecerebrovasdis.2021.106150. PMID: 34247053.
Lee S, Rivkin MJ, Kirton A, deVeber G, Elbers J; International Pediatric Stroke Study. Moyamoya Disease in Children: Results From the International Pediatric Stroke Study. J Child Neurol. 2017 Oct;32(11):924-929. doi : 10.1177/0883073817718730. Epub 2017 Jul 17. PMID: 28715924.
Strunk D, Bauer P, Keyvani K, Diehl RR, Veltkamp R, Berlit P, Meuth SG, Timmermann L, Schwitalla JC, Kraemer M. Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature. J Neurol. 2024 Jun;271(6):3328-3339. doi : 10.1007/s00415-024-12228-0. Epub 2024 Mar 13. PMID: 38478032; PMCID: PMC11136762.
Das S, Dubey S, Acharya M, Ghosh R, Chatterjee S, Hazra A, Lahiri D, Segupta S, Chatterjee S, Das G, Sarkar N, Ray BK, Kraemer M. The disease presentation of Moyamoya angiopathy in Eastern India . J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104957. doi : 10.1016/j.jstrokecerebrovasdis.2020.104957. Epub 2020 Jun 14. PMID: 32689603.
Ge P, Zhang Q, Ye X, Liu X, Deng Strokes. 2020 Aug;51(8):2472-2479. doi : 10.1161/STROKEAHA.120.030027. Epub 2020 Jul 9. PMID: 32640948.
Pilgram-Pastor S, Chapot R, Kraemer M. The angiographic presentation of European Moyamoya angiopathy. J Neurol. 2022 Feb;269(2):997-1006. doi : 10.1007/s00415-021-10684-6. Epub 2021 Jul 8. PMID: 34240321; PMCID: PMC8782787.
Hara S, Mukawa M, Akagawa H, Thamamongood T, Inaji M, Tanaka Y, Maehara T, Kasuya H, Nariai T. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients. J Neurosurg Pediatr . 2021 Oct 8;29(1):48-56. doi : 10.3171/2021. 7. PEDS 21250. PMID: 34624841.
Asselman C, Hemelsoet D, Eggermont D, Dermaut B, Impens F. Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. 2022 Nov;28(11):939-950. doi : 10.1016/j.molmed.2022.08.009. Epub 2022 Sep 14. PMID: 36115805.
Navandhar PS, Gharde P, Shinde RK, Nagtode T. Moyamoya Disease: Advances in Diagnosis, Treatment, and Surgical Interventions. Cureus . 2024 May 7;16(5 ):e 59826. doi : 10.7759/cureus.59826. PMID: 38846195; PMCID: PMC11156423.
Canavero I, Vetrano IG, Zedde M, Pascarella R, Gatti L, Acerbi F, Nava S, Ferroli P, Parati EA, Bersano A. Clinical Management of Moyamoya Patients. J Clin Med. 2021 Aug 17;10(16):3628. doi : 10.3390/jcm10163628. PMID: 34441923; PMCID: PMC8397113.
Rupareliya C, Lui F. Moyamoya Disease. [Updated 2023 Jun 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535455/
